RT Journal Article
SR Electronic
T1 Forecasting daily confirmed COVID-19 cases in Algeria using ARIMA models
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.18.20248340
DO 10.1101/2020.12.18.20248340
A1 Messis Abdelaziz
A1 Adjebli Ahmed
A1 Ayeche Riad
A1 Ghidouche Abderrezak
A1 Ait-Ali Djida
YR 2020
UL http://medrxiv.org/content/early/2020/12/20/2020.12.18.20248340.abstract
AB Coronavirus disease has become a worldwide threat affecting almost every country in the world. The aim of this study is to identify the COVID-19 cases (positive, recovery and death) in Algeria using the Double Exponential Smoothing Method and an Autoregressive Integrated Moving Average (ARIMA) model for forecasting the COVID-19 cases.The data for this study were obtained from March 21st, 2020 to November 26th, 2020. The daily Algerian COVID-19 confirmed cases were sourced from The Ministry of Health, Population and Hospital Reform of Algeria. Based on the results of PACF, ACF, and estimated parameters of the ARIMA model in the COVID-19 case in Algeria following the ARIMA model (0,1,1). Observed cases during the forecast period were accurately predicted and were placed within the prediction intervals generated by the fitted model. This study shows that ARIMA models with optimally selected covariates are useful tools for monitoring and predicting trends of COVID-19 cases in Algeria.Competing Interest StatementThe authors have declared no competing interest.Funding StatementConflict of Interest I like inform you that this is my first submission and this work was never submitted in any participation cited in your ethics section. For the literature cited in the manuscript, it has been fully acknowledged. The submission of this paper has been confirmed by all authors cited after my name and followed by their participation to the correction. So, all authors agree with this submission. The authors declare that they have no conflict of interest. Dr. MESSIS Abdelaziz Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Bordj Bou ArreridjAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesConflict of Interest I like inform you that this is my first submission and this work was never submitted in any participation cited in your ethics section. For the literature cited in the manuscript, it has been fully acknowledged. The submission of this paper has been confirmed by all authors cited after my name and followed by their participation to the correction. So, all authors agree with this submission. The authors declare that they have no conflict of interest. Dr. MESSIS Abdelaziz